Hepatitis C virus infection in patients undergoing surgery in a single tertiary academic center
Journal of Gastroenterology and Hepatology · 2024
DOI: 10.1111/jgh.16506 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Gastroenterology and Hepatology, 2024. Verfasst von Jae Seung Lee und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea. Hauptthemen laut MEDLINE: Tertiary Care Centers, Hepatitis C, Antiviral Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: Severance Hospital Research Fund for Clinical Excellence (SHRC), AbbVie Investigator-Initiated Studies.
Abstract (Originalsprache)
Background and Aim Lack of awareness disturbs proper care for hepatitis C virus (HCV) infections in patients undergoing surgery. We investigated the status of HCV screening, confirmation, and treatment in patients who underwent surgery.
Methods
Patients who underwent surgery at a tertiary academic center between 2019 and 2021 were eligible for this retrospective study.
Results
Between 2019 and 2021, 96 894 patients (40 121 males; 41.4%) who underwent surgery under general anesthesia were recruited. The median age of the participants was 55.0 years. Of the 83 920 (86.6%) patients who tested positive for anti‐HCV antibodies, 576 (0.7%) showed positive results, with a higher proportion of patients with diabetes mellitus (32.6% vs 18.5%), hypertension (50.5% vs 28.6%), liver cirrhosis (13.2% vs 1.7%), and unfavorable laboratory test results when compared with those with negative results (all P < 0.05). HCV RNA was tested in 215 patients (37.3%), with a positivity rate of 20.5% ( n = 44). Of the 44 patients, 42 (95.5%) were referred for antiviral treatment, and 29 (69.0%) were successfully treated with direct‐acting antiviral therapy. HCV RNA confirmation rates were higher in the Department of Hepatobiliary and Transplant Surgery (76.6%) than in the other surgical departments (25.0–33.5%) ( P < 0.001).
Conclusions
The proportion of patients who were positive for anti‐HCV antibodies and failed to receive proper management after surgery was not negligible. Increased awareness of HCV infection among surgeons through appropriate education may be required.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea.
- Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, South Korea.
- Yonsei Liver Center, Severance Hospital, Seoul, South Korea.
ORCID-Profile: Jae Seung Lee, Hye Won Lee, Mi Na Kim, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Seung Up Kim
Förderung
- Severance Hospital Research Fund for Clinical Excellence (SHRC)
- AbbVie Investigator-Initiated Studies
Zitieren
APA
Lee, J. S., Lee, H. W., Kim, M. N., Kim, B. K., Park, J. Y., Kim, D. Y., Ahn, S. H., & Kim, S. U. (2024). Hepatitis C virus infection in patients undergoing surgery in a single tertiary academic center. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.16506
Vancouver
Lee JS, Lee HW, Kim MN, Kim BK, Park JY, Kim DY, et al. Hepatitis C virus infection in patients undergoing surgery in a single tertiary academic center. Journal of Gastroenterology and Hepatology. 2024. doi:10.1111/jgh.16506
BibTeX
@article{Lee2024,
author = {Lee, Jae Seung and Lee, Hye Won and Kim, Mi Na and Kim, Beom Kyung and Park, Jun Yong and Kim, Do Young and Ahn, Sang Hoon and Kim, Seung Up},
title = {Hepatitis C virus infection in patients undergoing surgery in a single tertiary academic center},
journal = {Journal of Gastroenterology and Hepatology},
year = {2024},
doi = {10.1111/jgh.16506}
}
EUVIMED